Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian Cancer

Cell Reports - United States
doi 10.1016/j.celrep.2016.04.034
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Upregulation of MEK5 by Stat3 Promotes Breast Cancer Cell Invasion and Metastasis

Oncology Reports
MedicineCancer ResearchOncology
2016English

MicroRNA-101 Inhibits Growth and Metastasis of Human Ovarian Cancer Cells by Targeting PI3K/AKT

Archives of Medical Science
Medicine
2019English

MicroRNA-221-3p, a TWIST2 Target, Promotes Cervical Cancer Metastasis by Directly Targeting THBS2

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2017English

The Expression of microRNA-598 Inhibits Ovarian Cancer Cell Proliferation and Metastasis by Targeting URI

Molecular Therapy - Oncolytics
Cancer ResearchOncologyMolecular MedicinePharmacology
2019English

Dihydroartiminisin Inhibits the Growth and Metastasis of Epithelial Ovarian Cancer

Oncology Reports
MedicineCancer ResearchOncology
2011English

Potential microRNA-related Targets for Therapeutic Intervention With Ovarian Cancer Metastasis

Cancer Genomics and Proteomics
MedicineBiochemistryGeneticsMolecular BiologyCancer Research
2018English

MicroRNA-663 Facilitates the Growth, Migration and Invasion of Ovarian Cancer Cell by Inhibiting TUSC2

Biological Research
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgricultural
2019English

MicroRNA-127-3p Acts as a Tumor Suppressor in Epithelial Ovarian Cancer by Regulating the BAG5 Gene

Oncology Reports
MedicineCancer ResearchOncology
2016English

Transcriptional Repression of SOCS3 Mediated by IL-6/STAT3 Signaling via DNMT1 Promotes Pancreatic Cancer Growth and Metastasis

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy